Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAIDS: Compound Danshen Dripping Pill for Microvascular Angina
NCT06092736Phase 4Recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Dec 2018
- Primary completion
- Jun 2027
- Modality
- Botanical Extract
- Countries
- 1
01
Overview
A Phase 4 trial of Compound Danshen in microvascular angina (MVA), sponsored by Qilu Hospital of Shandong University. Started Dec 2018; status: recruiting.
02
Drugs
Compound Danshen
03
Conditions
microvascular angina (MVA)
Beyond the preview
Go deeper on NCT06092736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06092736.